BIOMAT Database Logo BIOMAT Database Logo

Rubella: current status of immunization. 1970

E L Quinn, and F Cox, and D Romig

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012409 Rubella An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM. Measles, German,Three Day Measles,German Measles,Measle, Three Day,Measles, Three Day,Rubellas,Three Day Measle
D012411 Rubella Vaccine A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed) Vaccine, Rubella
D012412 Rubella virus The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. Measles Virus, German,German Measles Virus
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral

Related Publications

E L Quinn, and F Cox, and D Romig
Rubella immunization of adult women: current status.
April 1972, California medicine,
E L Quinn, and F Cox, and D Romig
Current concepts of smallpox and rubella immunization.
January 1972, The Journal of the Maine Medical Association,
E L Quinn, and F Cox, and D Romig
Rubella immunization: present status and future perspectives.
June 1980, Pediatrics,
E L Quinn, and F Cox, and D Romig
Current Status of Immunization.
September 1961, Canadian Medical Association journal,
E L Quinn, and F Cox, and D Romig
Current status of the rubella problem.
January 1970, Cardio-vascular nursing,
E L Quinn, and F Cox, and D Romig
Current status of rubella susceptibility testing.
February 1972, The New England journal of medicine,
E L Quinn, and F Cox, and D Romig
Intralymphatic immunization: current status.
January 1977, European journal of cancer,
E L Quinn, and F Cox, and D Romig
CURRENT STATUS OF MEASLES IMMUNIZATION.
September 1963, Medical science,
E L Quinn, and F Cox, and D Romig
The current status of immunization.
October 1962, Military medicine,
E L Quinn, and F Cox, and D Romig
Current status of measles immunization.
December 1965, JAMA,
Copied contents to your clipboard!